Bio-Connect
Western blot analysis using anti-IL-33 (human), pAb (Prod. No. AG-25A-0045) at 1:2000 dilution. 1: Human IL-33 (His-tagged). 2: Unrelated protein (His-tagged) (negative control). 2: Human single chain IL-23 (FLAG®-tagged).
Western blot analysis using anti-IL-33 (human), pAb (Prod. No. AG-25A-0045) at 1:2000 dilution. 1: Human IL-33 (His-tagged). 2: Unrelated protein (His-tagged) (negative control). 2: Human single chain IL-23 (FLAG®-tagged).
Western blot analysis using anti-IL-33 (human), pAb (Prod. No. AG-25A-0045) at 1:2000 dilution. 1: Human IL-33 (His-tagged). 2: Unrelated protein (His-tagged) (negative control). 2: Human single chain IL-23 (FLAG®-tagged).

anti-IL-33 (human), pAb

Research Use Only
AG-25A-0045
AdipoGen Life Sciences
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetIL33
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    AdipoGen Life Sciences
  • Product Name
    anti-IL-33 (human), pAb
  • Delivery Days Customer
    10
  • Antibody Specificity
    Recognizes human IL-33. Detects a band of ~18kDa by Western blot.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Gene ID90865
  • Target name
    IL33
  • Target description
    interleukin 33
  • Target synonyms
    C9orf26; DVS27; DVS27-related protein; IL1F11; interleukin-1 family member 11; interleukin-33; NFEHEV; NF-HEV; nuclear factor for high endothelial venules; nuclear factor from high endothelial venules
  • Host
    Rabbit
  • Scientific Description
    Interleukin-33 (IL-33; HF-NEV; IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30kDa human IL33 is converted by CASP1 to a 18kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis. - Polyclonal Antibody. Recognizes human IL-33. Detects a band of ~18kDa by Western blot. Source: Rabbit. Applications: ELISA, IHC, WB. Liquid. 0.2microm-filtered solution in PBS, pH 7.4. Contains no preservatives. Interleukin-33 (IL-33; HF-NEV; IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30kDa human IL33 is converted by CASP1 to a 18kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C,-20°C
  • UNSPSC
    12352203